Clinical trial · Observational
Institut Paoli Calmettes Breast Cancer Database
NCT02869607CI-TRIAL-00023542recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Database of Institut Paoli-Calmettes patients diagnosed with breast cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Diagnosis | Breast Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Data collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with breast cancer diagnosis
- interventionNames
- Other: Data collection
Primary outcomes (1)
- measure
- Survival of patients with breast cancer
- timeFrame
- 10 years
- description
- Overall survival of all patients who come in the center
Secondary outcomes (1)
- measure
- Collection of patients characteristics
- timeFrame
- 10 years
- description
- Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient with a diagnosis of breast cancer Exclusion Criteria: \-
References
Publications (2)
- DERIVEDHouvenaeghel G, de Nonneville A, Cohen M, Sabiani L, Buttarelli M, Charaffe E, Jalaguier A, Bannier M, Tallet A, Viret F, Goncalves A. Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival. Cancer Med. 2024 Feb;13(3):e6930. doi: 10.1002/cam4.6930. Epub 2024 Feb 7. PMID 38327130
- DERIVEDHouvenaeghel G, de Nonneville A, Cohen M, Chopin N, Coutant C, Reyal F, Mazouni C, Gimbergues P, Azuar AS, Chauvet MP, Classe JM, Darai E, Martinez A, Rouzier R, de Lara CT, Lambaudie E, Barrou J, Goncalves A. Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort☆. ESMO Open. 2021 Jun;6(3):100151. doi: 10.1016/j.esmoop.2021.100151. Epub 2021 May 10. PMID 33984674